{"id":416097,"date":"2021-01-15T22:53:38","date_gmt":"2021-01-16T03:53:38","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=416097"},"modified":"2021-01-15T22:53:38","modified_gmt":"2021-01-16T03:53:38","slug":"biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\/","title":{"rendered":"BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. &#8211; BMRN"},"content":{"rendered":"<p>        <!--body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p>\nBIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. &#8211; BMRN\n<\/p>\n<p>NEW ORLEANS&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nFormer Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick &amp; Foti, LLC (\u201cKSF\u201d), announces that KSF has commenced an investigation into BioMarin Pharmaceutical Inc. (NasdaqGS: BMRN).\n<\/p>\n<p>\nOn August 19, 2020, the Company disclosed that it received a Complete Response Letter (\u201cCRL\u201d) from the FDA rejecting its Biologics License Application (\u201cBLA\u201d) for its product, valoctocogene roxaparvovec, and recommending two years of data from the Company\u2019s ongoing 270-301 study (Phase 3) and that the Company \u201ccomplete the Phase 3 Study and submit two-year follow-up safety and efficacy data on all study participants,\u201d thus requiring a lengthier study before approval would be considered.\n<\/p>\n<p>\nThereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period, violating federal securities laws, which remains ongoing.\n<\/p>\n<p>\nKSF\u2019s investigation is focusing on whether BioMarin\u2019s officers and\/or directors breached their fiduciary duties to BioMarin\u2019s shareholders or otherwise violated state or federal laws.\n<\/p>\n<p>\nIf you have information that would assist KSF in its investigation, or have been a long-term holder of BioMarin shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (<a rel=\"nofollow\" href=\"mailto:lewis.kahn@ksfcounsel.com\">lewis.kahn@ksfcounsel.com<\/a>), or visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ksfcounsel.com%2Fcases%2Fnasdaqgs-bmrn%2F&amp;esheet=52363014&amp;newsitemid=20210115005590&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.ksfcounsel.com%2Fcases%2Fnasdaqgs-bmrn%2F&amp;index=1&amp;md5=e7673918998738111e43c33e165d09c9\">https:\/\/www.ksfcounsel.com\/cases\/nasdaqgs-bmrn\/<\/a> to learn more.\n<\/p>\n<p>\nAbout Kahn Swick &amp; Foti, LLC\n<\/p>\n<p>\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation\u2019s premier boutique securities litigation law firms. KSF serves a variety of clients \u2013 including public institutional investors, hedge funds, money managers and retail investors \u2013 in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana.\n<\/p>\n<p>\nTo learn more about KSF, you may visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.ksfcounsel.com&amp;esheet=52363014&amp;newsitemid=20210115005590&amp;lan=en-US&amp;anchor=www.ksfcounsel.com&amp;index=2&amp;md5=c4713d81c0852e532c55f7ab59392ab5\">www.ksfcounsel.com<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210115005590r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210115005590\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210115005590\/en\/<\/a><\/span><\/p>\n<p>\nKahn Swick &amp; Foti, LLC<br \/>\n<br \/>Lewis Kahn, Managing Partner<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:lewis.kahn@ksfcounsel.com\">lewis.kahn@ksfcounsel.com<br \/>\n<\/a><br \/>1-877-515-1850\n<\/p>\n<p><b>KEYWORDS:<\/b> United States North America Louisiana<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Legal Professional Services<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210115005590\/en\/752156\/3\/logo-square-pr.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. &#8211; BMRN NEW ORLEANS&#8211;(BUSINESS WIRE)&#8211; Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick &amp; Foti, LLC (\u201cKSF\u201d), announces that KSF has commenced an investigation into BioMarin Pharmaceutical Inc. (NasdaqGS: BMRN). On August 19, 2020, the Company disclosed that it received a Complete Response Letter (\u201cCRL\u201d) from the FDA rejecting its Biologics License Application (\u201cBLA\u201d) for its product, valoctocogene roxaparvovec, and recommending two years of data from the Company\u2019s ongoing 270-301 study (Phase 3) and that the Company \u201ccomplete the Phase 3 Study and submit two-year follow-up safety &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. &#8211; BMRN&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-416097","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. &#8211; BMRN NEW ORLEANS&#8211;(BUSINESS WIRE)&#8211; Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick &amp; Foti, LLC (\u201cKSF\u201d), announces that KSF has commenced an investigation into BioMarin Pharmaceutical Inc. (NasdaqGS: BMRN). On August 19, 2020, the Company disclosed that it received a Complete Response Letter (\u201cCRL\u201d) from the FDA rejecting its Biologics License Application (\u201cBLA\u201d) for its product, valoctocogene roxaparvovec, and recommending two years of data from the Company\u2019s ongoing 270-301 study (Phase 3) and that the Company \u201ccomplete the Phase 3 Study and submit two-year follow-up safety &hellip; Continue reading &quot;BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. &#8211; BMRN&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-16T03:53:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210115005590r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. &#8211; BMRN\",\"datePublished\":\"2021-01-16T03:53:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\\\/\"},\"wordCount\":412,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210115005590r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\\\/\",\"name\":\"BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210115005590r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-01-16T03:53:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210115005590r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210115005590r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. &#8211; BMRN\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\/","og_locale":"en_US","og_type":"article","og_title":"BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN - Market Newsdesk","og_description":"BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. &#8211; BMRN NEW ORLEANS&#8211;(BUSINESS WIRE)&#8211; Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick &amp; Foti, LLC (\u201cKSF\u201d), announces that KSF has commenced an investigation into BioMarin Pharmaceutical Inc. (NasdaqGS: BMRN). On August 19, 2020, the Company disclosed that it received a Complete Response Letter (\u201cCRL\u201d) from the FDA rejecting its Biologics License Application (\u201cBLA\u201d) for its product, valoctocogene roxaparvovec, and recommending two years of data from the Company\u2019s ongoing 270-301 study (Phase 3) and that the Company \u201ccomplete the Phase 3 Study and submit two-year follow-up safety &hellip; Continue reading \"BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. &#8211; BMRN\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-16T03:53:38+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210115005590r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. &#8211; BMRN","datePublished":"2021-01-16T03:53:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\/"},"wordCount":412,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210115005590r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\/","name":"BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210115005590r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-01-16T03:53:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210115005590r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210115005590r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc-bmrn\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick &amp; Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. &#8211; BMRN"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/416097","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=416097"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/416097\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=416097"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=416097"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=416097"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}